• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在包括药物治疗管理服务的处方福利计划的基于选择的联合分析中,用于效用估计的分层贝叶斯方法的试点研究。

Pilot study of a hierarchical Bayes method for utility estimation in a choice-based conjoint analysis of prescription benefit plans including medication therapy management services.

作者信息

Wellman Gregory S, Vidican Carla

机构信息

Ferris State University, College of Pharmacy, 220 Ferris Drive, Big Rapids, MI 49307, USA.

出版信息

Res Social Adm Pharm. 2008 Sep;4(3):218-30. doi: 10.1016/j.sapharm.2007.08.002.

DOI:10.1016/j.sapharm.2007.08.002
PMID:18794033
Abstract

BACKGROUND

Consumers face an array of multiattribute prescription benefit insurance programs that include different access points (retail, supermarket, Internet, etc) and levels of pharmacist interaction (including medication therapy management services [MTMSs]). Because of this, there is a need for more sophisticated information to drive prescription benefit plan design.

OBJECTIVES

A pilot study to determine if choice-based conjoint (CBC) analysis with hierarchical Bayes (HB) estimation for individual level part-worths could provide a stable model for attribute preferences for prescription benefit insurance; to pilot test the addition of MTMSs to a prescription benefit management model; and to pilot and compare logit-based utility estimates to HB estimations in a conjoint market simulator.

METHODS

A mail-based survey was conducted using a random sample of 1500 residents of the United States. A CBC analysis instrument was developed to provide a single-stated choice from a selection of different prescription benefit plans. Choice tasks were varied based on the attributes: co-payment, pharmacy access, formulary, level of pharmacist interaction including MTMSs and monthly premium. Analysis included logit-based and HB estimation for utilities, and preference share market simulation testing.

RESULTS

The utility estimations from HB analysis were consistent with those seen in the logit-based analysis. A goodness of fit of 83% (root likelihood) was achieved in the HB utility estimations with only 4 choice tasks per respondents and the inclusion of MTM-like services. There was convergence on preference shares from the market simulation between the 2 estimation methods.

CONCLUSIONS

The use of CBC analysis with HB estimation provided utilities similar to those estimated using aggregated logit-based methods, with the added benefit of respondent specific part-worth scores for each attribute level. A larger sample, changes in the instrument design, more panels (tasks) per respondent, and selection of conjoint methods may allow for more predictive information from market simulators.

摘要

背景

消费者面临一系列多属性的处方药福利保险计划,这些计划包括不同的获取途径(零售、超市、互联网等)以及不同水平的药剂师互动(包括药物治疗管理服务[MTMS])。因此,需要更复杂的信息来推动处方药福利计划的设计。

目的

进行一项试点研究,以确定使用具有层次贝叶斯(HB)估计个体水平部分价值的基于选择的联合分析(CBC)是否能为处方药福利保险的属性偏好提供一个稳定的模型;对在处方药福利管理模型中增加MTMS进行试点测试;并在联合市场模拟器中对基于logit的效用估计与HB估计进行试点和比较。

方法

对1500名美国居民的随机样本进行了基于邮件的调查。开发了一种CBC分析工具,以便从不同的处方药福利计划中进行单一陈述选择。选择任务根据以下属性而变化:共付额、药房获取途径、药品目录、包括MTMS在内的药剂师互动水平以及月保费。分析包括基于logit和HB的效用估计,以及偏好份额市场模拟测试。

结果

HB分析的效用估计与基于logit的分析结果一致。在HB效用估计中,每个受访者仅进行4个选择任务并纳入类似MTM的服务时,拟合优度达到了83%(根似然)。两种估计方法在市场模拟的偏好份额上趋于一致。

结论

使用带有HB估计的CBC分析所提供的效用与使用基于logit的汇总方法估计的效用相似,其额外好处是为每个属性水平提供受访者特定的部分价值分数。更大的样本、工具设计的改变、每个受访者更多的面板(任务)以及联合方法的选择可能会从市场模拟器中获得更多预测信息。

相似文献

1
Pilot study of a hierarchical Bayes method for utility estimation in a choice-based conjoint analysis of prescription benefit plans including medication therapy management services.在包括药物治疗管理服务的处方福利计划的基于选择的联合分析中,用于效用估计的分层贝叶斯方法的试点研究。
Res Social Adm Pharm. 2008 Sep;4(3):218-30. doi: 10.1016/j.sapharm.2007.08.002.
2
Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.药剂师可接受的 MTM 服务补偿水平:联合分析。
Res Social Adm Pharm. 2011 Dec;7(4):383-95. doi: 10.1016/j.sapharm.2010.09.003. Epub 2010 Nov 5.
3
A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.5种处方福利计划中邮购服务药房与零售社区药房索赔情况的比较。
Res Social Adm Pharm. 2009 Jun;5(2):133-42. doi: 10.1016/j.sapharm.2008.06.002. Epub 2009 Jan 31.
4
Judgment processes in older adults' drug benefit evaluations.老年人药物效益评估中的判断过程。
Res Social Adm Pharm. 2005 Mar;1(1):5-20. doi: 10.1016/j.sapharm.2004.12.004.
5
Choices in prescription-drug benefit programs: mail versus community pharmacy services.处方药福利计划中的选择:邮购药房与社区药房服务
Milbank Q. 1990;68(1):29-51.
6
Factors affecting demand among older adults for medication therapy management services.影响老年人对药物治疗管理服务需求的因素。
Res Social Adm Pharm. 2008 Dec;4(4):309-19. doi: 10.1016/j.sapharm.2007.11.003. Epub 2008 Aug 8.
7
Pharmacist-provided medication therapy management (part 2): Payer perspectives in 2007.药剂师提供的药物治疗管理(第2部分):2007年支付方视角
J Am Pharm Assoc (2003). 2008 Jul-Aug;48(4):478-86. doi: 10.1331/JAPhA.2008.08023.
8
Employee knowledge of a managed pharmacy benefit in a large corporation.大型企业中员工对管理式药房福利的了解。
Manag Care Interface. 2005 Jan;18(1):33-42.
9
Drug benefit decisions among older adults: a policy-capturing analysis.老年人的药物效益决策:一项政策捕捉分析。
Med Decis Making. 2006 May-Jun;26(3):273-81. doi: 10.1177/0272989X06288682.
10
The effect of information on preferences stated in a choice-based conjoint analysis.基于选择的联合分析中所陈述信息对偏好的影响。
Patient Educ Couns. 2009 Feb;74(2):264-71. doi: 10.1016/j.pec.2008.08.025. Epub 2008 Oct 26.

引用本文的文献

1
Patient preferences and cost-benefit of hypertension and hyperlipidemia collaborative management model between pharmacies and primary care in Portugal: A discrete choice experiment alongside a trial (USFarmácia®).葡萄牙药房与基层医疗合作管理高血压和高血脂模式的患者偏好和成本效益:一项伴随试验的离散选择实验(USFarmácia®)。
PLoS One. 2023 Oct 5;18(10):e0292308. doi: 10.1371/journal.pone.0292308. eCollection 2023.
2
Preferences for policy measures to regulate urban vehicle access for climate change mitigation.缓解气候变化的城市车辆准入监管政策措施偏好。
Environ Sci Eur. 2023;35(1):42. doi: 10.1186/s12302-023-00745-0. Epub 2023 Jun 6.
3
Patient and Public Preferences for Coordinated Care in Switzerland: Development of a Discrete Choice Experiment.
瑞士协调护理的患者和公众偏好:离散选择实验的制定。
Patient. 2022 Jul;15(4):485-496. doi: 10.1007/s40271-021-00568-2. Epub 2022 Jan 24.
4
Implementation of a Medicare Plan Selection Assistance Program Through a Community Partnership.通过社区合作实施医疗保险计划选择援助计划。
Am J Pharm Educ. 2018 Nov;82(9):6452. doi: 10.5688/ajpe6452.
5
Discrete choice experiments of pharmacy services: a systematic review.药学服务的离散选择实验:一项系统评价。
Int J Clin Pharm. 2016 Jun;38(3):620-30. doi: 10.1007/s11096-015-0221-1.
6
Developing attributes and attribute-levels for a discrete choice experiment on micro health insurance in rural Malawi.为马拉维农村地区的小额健康保险离散选择实验开发属性和属性水平。
BMC Health Serv Res. 2014 May 22;14:235. doi: 10.1186/1472-6963-14-235.
7
A novel clinical pharmacy management system in improving the rational drug use in department of general surgery.一种新型临床药学管理系统在普外科合理用药中的应用
Indian J Pharm Sci. 2013 Jan;75(1):11-5. doi: 10.4103/0250-474X.113531.